IRONWOOD PHARMACEUTICALS INC [IRWD] - Ironwood Pharmaceuticals appoints Tammi Gaskins as CEO
Tammi Gaskins will succeed Tom McCourt as Chief Executive Officer and a member of the Board of Directors, effective January 1, 2027.
Why this matters
Ironwood Pharmaceuticals, a biotechnology company focused on developing therapies for gastrointestinal and rare diseases, has appointed Tammi Gaskins as its new Chief Executive Officer, effective January 1, 2027. This planned succession follows the retirement of current CEO Tom McCourt, who will remain on the Board of Directors. Gaskins, who has been with Ironwood since 2020 as Chief Commercial Officer, played a key role in revitalizing LINZESS, a leading treatment for irritable bowel syndrome with constipation, and advancing apraglutide for short bowel syndrome. Prior to her tenure at Ironwood, she held various commercial leadership roles at AstraZeneca over a 20-year period.